Introduction - the problem:Without the constant development and provision of novel tools and instruments that are needed for doing experimental life science research, the immense progress in basic research and the global advancement of biomedical innovation would not be possible. It has been the continuous development of methods, techniques,...
Introduction - the problem:Dynamic Biosensors is a young biotech company based in Munich, Germany, focused on the development and marketing of our pioneering and award-winning switchSENSE® technology for molecular interaction analysis. We provide solutions to academic and industry partners in the areas of biophysical analysis and drug discovery.
Our just-launched...
Introduction - the problem:Merkel cell carcinoma (MCC) is a rare and agressive skin cancer with a 5-year overall survival of 40%. Patients are first treated with platinum-based chemotherapies but there is no benefit on survival. Immune checkpoint inhibitors were a revolution in MCC treatment however, on long term, 75%...
Introduction - the problem:We are at the dawn of a new era: the omic era. Genomics – the analysis of the inherited gene set of each individual is already an advanced technology broadly applied in population-wide studies and entered public life. The next level of ‘omic’ technologies is advancing,...